Fig. 3: Study design for ultrasound tomography scans and endocrine symptom assessment in the Ultrasound Study of Tamoxifen.
Ultrasound tomography scans and endocrine symptoms were ascertained prior to tamoxifen initiation (T0) and post-tamoxifen initiation (T1–T3).
